Alicja Nowaczyk | Medicinal Chemistry | Innovative Research Award

Published on by Analytical Chemistry

Innovative Research Award

Alicja Nowaczyk
NCU, Poland

Alicja Nowaczyk
Name Alicja Nowaczyk
Affiliation NCU
Country Poland
Subject Area Medicinal Chemistry
Event Name International Analytical Chemistry Awards
ORCID 0000-0003-4945-2369

The Innovative Research Award recognizes research initiatives that introduce original approaches, methodologies, or applications within scientific disciplines. Alicja Nowaczyk, affiliated with NCU in Poland, is associated with the field of Medicinal Chemistry and is presented in connection with the International Analytical Chemistry Awards. This profile outlines the available academic information and the relevance of innovation-oriented research recognition.

Abstract

This academic recognition profile presents Alicja Nowaczyk of NCU, Poland, in the context of the Innovative Research Award associated with the International Analytical Chemistry Awards. The researcher’s stated subject area is Medicinal Chemistry. This discipline contributes to pharmaceutical research through the investigation of chemical structures, molecular interactions, and biologically relevant compounds. Detailed publication records, citation indicators, and specific research achievements have not been independently established for this profile.

Keywords

Innovative Research Award; Alicja Nowaczyk; Medicinal Chemistry; Analytical Chemistry; Drug Discovery; Molecular Design; Pharmaceutical Research; Scientific Innovation; Research Recognition; Poland.

Introduction

Innovation in medicinal chemistry frequently involves the development of chemical strategies that address challenges in therapeutic research. These strategies can include the optimization of molecular properties, improvements in synthetic efficiency, and the application of analytical techniques to characterize candidate compounds. Reliable research evaluation considers the quality of evidence, reproducibility, and the relationship between a study’s objectives and its reported findings. [2]

Research Profile

Alicja Nowaczyk is identified in the supplied information as a researcher affiliated with NCU in Poland, with Medicinal Chemistry listed as the subject area. An ORCID identifier is provided to support researcher identification and scholarly record management. ORCID enables researchers to distinguish their work from that of individuals with similar names. [1] Additional institutional, bibliographic, and career details require verification through authoritative academic sources.

Research Contributions

The available information identifies Medicinal Chemistry as the researcher’s academic subject area but does not provide specific research papers, laboratory findings, patents, or documented discoveries. Consequently, particular contributions cannot be attributed without supporting evidence. In general, contributions in medicinal chemistry may be assessed through the originality of compound design, experimental methodology, analytical validation, and the scientific significance of published results. [3]

Publications

No verified publication list has been supplied for this profile. A comprehensive publication assessment should include peer-reviewed articles, review papers, conference contributions, and other scholarly outputs that can be reliably associated with the researcher. Bibliographic databases such as Scopus can assist in identifying publications and citation records, although author identity should be checked carefully to reduce the possibility of attribution errors. [4]

Research Impact

Research impact may be examined through scholarly citations, collaboration, methodological adoption, practical applications, and contributions to scientific knowledge. In medicinal chemistry, potential impact can also relate to the development of useful chemical tools or advances in drug-discovery research. However, no independently verified impact indicators are available for Alicja Nowaczyk in the supplied data. Any quantitative assessment should therefore be based on documented sources.

Award Suitability

The Innovative Research Award is presented in connection with the International Analytical Chemistry Awards. Medicinal chemistry is related to analytical chemistry through the characterization, measurement, and evaluation of chemical substances. [5] A formal award assessment would ordinarily require documented evidence of originality, research quality, relevant publications, and compliance with the event’s evaluation criteria. Eligibility or selection cannot be confirmed solely from the information provided.

Conclusion

Alicja Nowaczyk is identified as a researcher affiliated with NCU in Poland and associated with Medicinal Chemistry. The profile records an ORCID identifier and the Innovative Research Award category linked to the International Analytical Chemistry Awards. Specific academic achievements and research impact indicators remain unverified. Further documentation would be necessary to establish a comprehensive scholarly profile and evaluate award-related qualifications.

References

  1. ORCID. (n.d.). ORCID: Connecting research and researchers. ORCID.https://orcid.org/
  2. Wermuth, C. G. (Ed.). (2008). The Practice of Medicinal Chemistry (3rd ed.). Academic Press.https://doi.org/10.1016/B978-0-12-374194-3.X0001-3
  3. Patrick, G. L. (2017). An Introduction to Medicinal Chemistry (6th ed.). Oxford University Press.https://global.oup.com/academic/
  4. Elsevier. (n.d.). Scopus: Abstract and citation database. Elsevier.https://www.scopus.com/
  5. International Union of Pure and Applied Chemistry. (n.d.). Analytical Chemistry and related scientific resources. IUPAC.https://iupac.org/

Dmitry Bordin | Medicinal Chemistry | Innovative Research Award

Published on by Analytical Chemistry

Innovative Research Award

Dmitry Bordin
Affiliation A.S. Loginov Moscow Clinical Scientific Center
Country Russia
Scopus ID 58709294500
Documents 3,801 Citations by 2,813 documents
Citations 209
h-index 27
Subject Area Medicinal Chemistry
Event International Analytical Chemistry Awards
Google Scholar jkHHA7sAAAAJ&hl
ORCID 0000-0003-2815-3992

Dmitry Bordin
A.S. Loginov Moscow Clinical Scientific Center, Russia

Dmitry Bordin is affiliated with the A.S. Loginov Moscow Clinical Scientific Center, Russia, and has been recognized within the field of medicinal chemistry for contributions to clinical and translational research. His scholarly activities encompass publication, collaboration, and dissemination of research findings relevant to modern biomedical science and analytical methodologies.[1] [2]

Dmitry Bordin

Institution: A.S. Loginov Moscow Clinical Scientific Center, Russia

Abstract

This article presents an academic recognition profile of Dmitry Bordin in connection with the Innovative Research Award associated with the International Analytical Chemistry Awards. The profile summarizes institutional affiliation, research activity, publication record, citation indicators, and scholarly influence within medicinal chemistry and related biomedical disciplines. The objective is to provide a neutral overview of academic achievements and research relevance based on publicly accessible scholarly metrics and professional records.[1] [3]

Keywords

Medicinal Chemistry; Clinical Research; Scholarly Impact; Scientific Publications; Citation Analysis; Analytical Chemistry; Biomedical Science; Research Recognition; Academic Awards; Translational Medicine.

Introduction

Academic recognition programs frequently evaluate researchers on the basis of publication quality, citation performance, scientific influence, and contributions to disciplinary advancement. Dmitry Bordin’s academic profile reflects sustained engagement with scholarly research and participation in scientific communication channels that contribute to evidence-based medical and chemical sciences.[1] [4]

Research Profile

Dmitry Bordin is associated with the A.S. Loginov Moscow Clinical Scientific Center and has developed a research portfolio linked to medicinal chemistry and biomedical investigation. Scholarly indicators identify an h-index of 27 and a publication and citation record demonstrating ongoing engagement with the international research community. Such indicators are commonly utilized to evaluate productivity, visibility, and scientific influence within academic environments.[1] [5]

Research Contributions

The research contributions associated with Dmitry Bordin encompass scientific investigations that support advancements in medical and chemical knowledge. Areas of contribution include clinical applications, analytical methodologies, translational research frameworks, and evidence generation relevant to patient-centered healthcare. These activities contribute to broader scientific understanding and interdisciplinary collaboration among researchers and healthcare professionals.[2] [3]

Publications

Publication activity serves as a central measure of academic contribution. Available scholarly records indicate substantial engagement with peer-reviewed research outputs and scientific dissemination. Publications attributed to the researcher contribute to ongoing discussions in medicinal chemistry, biomedical sciences, and associated analytical domains. Citation activity associated with these works suggests continued academic relevance and scholarly visibility.[1] [5]

Research Impact

Research impact may be evaluated through citation metrics, academic engagement, knowledge transfer, and influence on subsequent investigations. The documented citation profile and h-index indicate that the researcher’s scholarly outputs have been referenced within the scientific literature, reflecting measurable influence and ongoing utilization of published findings by other researchers.[1] [5]

Award Suitability

Based on publicly available scholarly indicators, institutional affiliation, publication activity, and citation performance, Dmitry Bordin demonstrates characteristics commonly associated with consideration for academic recognition programs such as the Innovative Research Award. Evaluation of suitability is typically conducted through a combination of qualitative peer review and quantitative performance indicators, including research productivity, innovation, and scholarly influence.[3] [5]

Conclusion

Dmitry Bordin’s academic profile reflects sustained participation in scientific research, publication, and scholarly communication. The available metrics and professional affiliations indicate a record of contribution within medicinal chemistry and related biomedical fields. Recognition through research award programs may serve to acknowledge ongoing efforts in advancing scientific knowledge and fostering research excellence.[1] [2]

References

  1. Elsevier. (n.d.). Scopus author details: Dmitry Bordin, Author ID 58709294500. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=58709294500
  2. ORCID. (n.d.). Dmitry Bordin researcher profile.
    https://orcid.org/0000-0003-2815-3992
  3. International Analytical Chemistry Awards. (n.d.). Award program and evaluation framework.
    https://analyticalchemistry.org/
  4. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output.
    DOI: https://doi.org/10.1073/pnas.0507655102
  5. Google Scholar. (n.d.). Scholar citation metrics and academic impact indicators.
    https://scholar.google.com/citations?user=jkHHA7sAAAAJ&hl=en&oi=ao

Muhammad Khan | Chemical Biology | Research Excellence Award

Published on by Analytical Chemistry

Dr.  Muhammad Khan | Chemical Biology | Research Excellence Award

Federal Urdu University of Arts, Sciences, & Technology | Pakistan

Dr. Muhammad Khan’s research focuses on integrated drug discovery combining computational and experimental pharmacology. He applies bioinformatics, molecular docking, QSAR, and ADMET prediction to identify potential therapeutic compounds. His work emphasizes natural products, particularly phytochemicals, targeting cancer, inflammation, and metabolic disorders. He is skilled in in vitro assays such as ELISA, MTT, and molecular techniques including PCR and Western blotting, alongside in vivo evaluations following OECD guidelines. His research also explores nanoparticle-based drug delivery and advanced analytical techniques, contributing to the development of safe, effective, and innovative pharmacological agents with strong translational potential.

Citation Metrics (Scopus)

1000
 500
 100
   20
     0

Citations
810

Documents
17

h-index
9

Citations

Documents

h-index

View Scopus Profile

Featured Publications

Nickson Samoo | Medicinal Chemistry | Young Scientist Award

Published on by Analytical Chemistry

Mr. Nickson Samoo | Medicinal Chemistry | Young Scientist Award

Kenya Medical Research Institute | Kenya

Nickson Kipkemoi Samoo is a medical research professional with over three years of experience in parasitology and entomology, currently pursuing a Master’s degree at the KEMRI Graduate School. He works within the Schistosomiasis Division at the Centre for Biotechnology Research and Development, focusing on vector biology and disease control strategies. His research evaluates the molluscicidal potential and phytochemical profiles of green and purple tea extracts against schistosomiasis vector snails. Nickson has strong expertise in statistical analysis, journal editing, and laboratory protocol standardization, contributing to impactful, data-driven public health research.

View ORCID Profile

Featured Publication

Yuhao Jiang | Medicinal Chemistry | Medical Chemistry Award

Published on by Analytical Chemistry

Dr. Yuhao Jiang | Medicinal Chemistry | Medical Chemistry Award

Beijing Normal University | China

Yuhao Jiang is a Postdoctoral Researcher at the Beijing Normal University, specializing in radiopharmaceuticals for bacterial infection and tumor imaging. With a BSc and PhD in Chemistry/Medicinal Chemistry & Molecular Engineering, his research focuses on the design, radiolabeling, and preclinical evaluation of novel imaging probes using ^99mTc, ^68Ga, and Al^18F. He has developed radiolabeled antibacterial peptides, iron carriers, and molecular probes with improved targeting and imaging performance. Jiang has published 8 SCI-indexed papers, holds 4 patents, and actively contributes to national and provincial research projects. His work supports clinical translation and industry collaboration in nuclear medicine.

Citation Metrics (Scopus)

 350
 250
 150
   50
     0

Citations
267

Documents
43

h-index
9

Citations

Documents

h-index

View Scopus Profile View ORCID Profile

Featured Publications

Mostafa Ahmed | Organic Chemistry | Research Excellence Award

Published on by Analytical Chemistry

Prof. Mostafa Ahmed | Organic Chemistry | Research Excellence Award

New Valley University | Egypt

Prof. Mostafa Mohamd Ahmed Ahmed is a distinguished organic and pharmaceutical chemist whose research integrates bioorganic, medicinal, supramolecular, polymer, and nanochemistry. His work focuses on the design and synthesis of heterocyclic compounds, cucurbituril-based host–guest systems, and functional organic materials with applications in drug discovery, antimicrobial and anti-inflammatory agents, corrosion inhibition, luminescent materials, energy storage, and wastewater treatment. He has made notable contributions to aggregation-induced emission (AIE) systems, molecular recognition, and bioactive heterocycles such as thienopyrimidines and indole derivatives. With over 45 peer-reviewed publications, extensive international collaborations, competitive funding, and advanced spectroscopic and analytical expertise, his research bridges fundamental chemistry with applied technological and biomedical solutions.

Citation Metrics (Scopus)

 1100
 800
 500
  200
     0

Citations
840

Documents
44

h-index
20

Citations

Documents

h-index

View Scopus Profile View Google Scholar Profile

Featured Publications

Andrew Tsotinis | Medicinal Chemistry | Research Excellence Award

Published on by Analytical Chemistry

Prof. Andrew Tsotinis | Medicinal Chemistry | Research Excellence Award

National and Kapodistrian University of Athens | Greece

Professor Tsotinis is a distinguished researcher in synthetic organic and medicinal chemistry with a strong focus on the development of novel synthetic methodologies and bioactive molecular frameworks. His research is dedicated to the design, synthesis, and optimization of organic compounds with diverse pharmacological activities, including antineoplastic, antiviral, antibacterial, antitubercular, trypanocidal, and central nervous system (CNS) applications. A significant component of his work involves the structural modification of bioactive natural products, such as melatonin and its derivatives, to enhance therapeutic efficacy and selectivity. Drawing on experience from both academic and industrial research environments, his studies effectively bridge fundamental organic synthesis and applied pharmaceutical chemistry. Professor Tsotinis has authored more than 120 peer-reviewed scientific publications and is the inventor or co-inventor of numerous European and U.S. patents, highlighting the translational impact of his research. He has led and co-led a large number of competitive research programs and has extensively supervised doctoral, postgraduate, and professional pharmacy research projects, contributing significantly to advanced training and innovation in chemical and pharmaceutical sciences.

Citation Metrics (Scopus)

1900
1300
700
100
0

Citations
1,790

Documents
93

h-index
23

Citations

Documents

h-index

View Scopus Profile View Google Scholar Profile

Featured Publications

Rajwinder Kaur | Medicinal Chemistry | Outstanding Educator Award

Published on by Analytical Chemistry

Dr. Rajwinder Kaur | Medicinal Chemistry | Outstanding Educator Award

Chitkara University | India

Dr. Rajwinder Kaur is a distinguished pharmaceutical chemist, academic leader, and researcher with over 16 years of experience in teaching, research, and academic administration. Currently serving as Assistant Dean (PharmD Program) and Professor, she has made significant contributions to pharmaceutical chemistry, drug design, and therapeutic innovation. Her research focuses on computer-aided drug design (CADD), the discovery of novel chemical entities as adenosine receptor ligands, and the development of therapeutic agents for asthma, inflammation, Alzheimer’s disease, depression, and neuroprotection. She has also advanced the scientific understanding of natural products by identifying phytoconstituents with antidepressant, neuroprotective, anti-inflammatory, and antifungal potential. As Principal Investigator, she successfully completed a prestigious DST Women Scientist (WOS-A) project on thiophene derivatives. Dr. Kaur’s scholarly contributions include impactful publications in high-ranking international journals such as Chemistry Africa, Frontiers in Pharmacology, Journal of Biomolecular Structure and Dynamics, Pharmaceutics, Pharmaceuticals, Polymers, CNS Medicinal Chemistry, and more. Her work spans synthetic chemistry, molecular modeling, nanocarrier-based drug delivery systems, biomarker discovery, and MAO-A inhibitor development. She has authored multiple books with NOVA Science Publishers, highlighting her multidisciplinary expertise. With a strong innovation portfolio, she holds several patents related to thiophene derivatives, novel drug-delivery devices, chemical catalyzers, and therapeutic compounds. Her excellence has been recognized through numerous honors, including the Best Faculty Award, Young Scientist Awards, Gold Medals, and several national accolades. She is also an active member of globally recognized professional bodies such as the ACS, HKCBEES, and APTI. Through her impactful research, innovation, mentoring, and leadership, Dr. Rajwinder Kaur continues to shape the future of pharmaceutical sciences and stands as an exemplary researcher and educator.

Profiles : Scopus | ORCID | Google Scholar

Featured Publications

1. Choudhary, D., Kaur, R., Rani, N., Kumar, B., Singh, T. G., Chandrasekaran, B., Rawat, R., & Eyupoglu, V. (2025). Insights into in silico analysis to explore the multitarget antidepressant role of Camellia sinensis. Journal of Biomolecular Structure and Dynamics, 1–13.

2. Rani, A., Kaur, R., Aldahish, A., Vasudevan, R., Balaji, P., Dora, C. P., Chandrasekaran, B., Singh, T. G., & Sharma, R. (2025). Nanostructured lipid carriers (NLC)-based topical formulation of hesperidin for effective treatment of psoriasis. Pharmaceutics, 17(4), 478.

3. Choudhary, D., Kumar, B., Chandrasekaran, B., Singh, T. G., Kaur, R., Aldahish, A., Vasudevan, R., & Balaji, P. (2025). Microwave-assisted synthesis of morpholine-based chalcones as reversible MAO-A inhibitors in the management of mental depression. Pharmaceuticals, 18(3), 309.

4. Singh, J. K., Kaur, S., Chandrasekaran, B., Kaur, G., Saini, B., Kaur, R., Silakari, P., Kaur, N., & Bassi, P. (2024). A QbD-navigated approach to the development and evaluation of etodolac–phospholipid complex containing polymeric films for improved anti-inflammatory effect. Polymers, 16(17), 2517.

5. Singh, R., Rani, N., Kaur, R., Chahal, G., Kumar, P., & Kaur, G. (2024). Exploring the therapeutic potential of alkaloids in Alzheimer’s disease management. Central Nervous System Agents in Medicinal Chemistry, 24(2), 206–218.

Abolfazl Olyaei | Organic Chemistry | Best Researcher Award

Published on by Analytical Chemistry

Assoc. Prof. Dr. Abolfazl Olyaei | Organic Chemistry | Best Researcher Award

Imam Khomeini International University | Iran

Dr. Abolfazl Olyaei is an associate professor at Imam Khomeini International University, Qazvin. He earned his B.Sc. in Pure Chemistry from Tabriz University and completed his M.Sc. in Organic Chemistry at Tehran University under Professor Mohammad Raouf Darvich. He continued his studies at Tehran University, receiving a Ph.D. in Organic Chemistry, supervised by Professor Mehdi Ghandi. Dr. Olyaei’s research focuses on organic synthesis, particularly the synthesis of heterocyclic compounds, multicomponent reactions, green chemistry, catalysis, organocatalysis, and the application of materials and organomaterials across various scientific fields. Over the years, he has contributed extensively to scientific literature, authoring numerous research and review articles in reputable journals, highlighting his expertise and impact in organic and heterocyclic chemistry. He has authored 89 research documents with 908 citations recorded by Scopus and an h-index of 17, while Google Scholar reports over 1091 citations and an h-index of 19. His work integrates modern synthetic methods with environmentally friendly approaches, contributing to advancements in catalysis and material science. Dr. Olyaei’s academic dedication and prolific publication record make him a prominent figure in the field of organic chemistry in Iran and internationally.

Profiles : Scopus | Orcid | Google scholar 

Featured Publications

Sajjadi, S. B., Olyaei, A., & Shalbafan, M. (2025). Novel naphtho[2,3-b]furan-2,4,9(3H)-trione derivatives as potent ERα inhibitors: Design, regioselective synthesis, HMBC-NMR characterization, in silico molecular docking and ADME studies. BMC Chemistry, 19(1), 253.

Shalbafan, M., Sadeghpour, M., & Olyaei, A. (2025). Study on the interaction of Olmesartan with human serum albumin (HSA) by spectroscopic and molecular docking techniques. Chemical Review and Letters, 8(3), 509–516.

Olyaei, A., Zanjanchi, F., Farzogi, M., & Sadeghpour, M. (2025). Comparative study of electronic structure and photophysical properties of some new Lawsone dyes in dye-sensitized solar cells by DFT and TD-DFT. Russian Journal of Physical Chemistry B, 19(2), 336–347.

Olyaei, A., Sadeghpour, M., & Sajjadi, S. B. (2025). A review on synthesis of furonaphthoquinones through Lawsone derivatives annulation reactions and their biological properties. RSC Advances, 15(5), 3515–3546.

Kayyal, M., Olyaei, A., Pourshamsian, K., & Sadeghpour, M. (2025). Molecular docking and prediction of ADME/drug-likeness properties of some benzochromenopyrimidine derivatives as inhibitors of cyclooxygenase 2 (COX-2). Chemical Review and Letters, 8(2), 300–308.

Shizhen Zhao | Organic Chemistry | Best Researcher Award

Published on by Analytical Chemistry

Dr. Shizhen Zhao | Organic Chemistry | Best Researcher Award

Guangzhou Institute of Geochemistry, Chinese Academy of Sciences, China

👨‍🎓Profiles

👨‍🎓 Early Academic and Research Foundations

Dr. Shizhen Zhao has pursued a career deeply rooted in environmental geochemistry and pollutant dynamics. From the early stages of his academic training, he has been engaged in the study of organic pollutants, combining field-based investigations with advanced numerical simulations to understand their transport, transformation, and long-term impact on ecosystems.

🧪 Professional Endeavors and Research Projects

Currently serving at the Guangzhou Institute of Geochemistry, Chinese Academy of Sciences, Dr. Zhao leads multiple high-impact environmental research initiatives. A central focus of his current work is the International Science and Technology Cooperation Project titled:
“Historical evolution of the aquatic environment in the CKDu region of Sri Lanka: Sedimentation of an ancient impoundment lake.”
This project addresses the agricultural water environment in Sri Lanka, specifically examining its links with the chronic kidney disease of unknown cause (CKDu)—a significant public health crisis. The project is conducted through China-Sri Lanka bilateral cooperation and aims to reconstruct historical water environment changes using sediment geochemistry and assess their spatiotemporal correlation with CKDu.

🌱 Contributions and Research Focus

Dr. Zhao’s research stands out in its integration of geochemical tools (e.g., ICP-MS, GC-MS, LC-MS/MS, HPLC) with epidemiological data and historical sediment analysis from ancient water tanks (AWTs). His team applies external observation methods, soil and air pollutant analysis, and field sampling techniques, aiming to uncover the origins, behavior, and human health risks of organic contaminants in vulnerable regions. This work represents a pioneering fusion of environmental forensics, historical ecology, and public health research.

🌍 International Cooperation and Collaboration

With over three years of active collaboration with Sri Lankan institutions and nearly 20 academic exchange visits, Dr. Zhao has built strong international ties. His research team also works closely with scholars from Hong Kong, sharing a decade-long history of cooperative projects and joint publications. These collaborations ensure multidisciplinary expertise, complementary methodologies, and smooth project execution.

🧾 Recognitions and Achievements

Dr. Zhao’s excellence has been recognized by several prestigious awards and talent programs, including:

  • Youth Innovation Promotion Association Award, Chinese Academy of Sciences

  • Tu Guangchi Young Scholar B Talent Program

  • Pearl River Talent—Overseas Young Talent Introduction Plan, Guangdong Province

He has also published 5 papers as first/corresponding author in the top-tier journal Environmental Science & Technology, with 2 selected as supplementary cover features—a rare distinction.

📊 Academic Output and Impact

Dr. Zhao has published over 22 SCI-indexed papers, many in high-impact journals. His research contributes significantly to understanding pollutant source attribution, environmental risks, and geochemical reconstruction of aquatic systems in Southeast Asia. His field investigations, especially in CKDu-endemic zones, are backed by rich epidemiological datasets and extensive regional insights.

🛠️ Technical and Field Capabilities

Equipped with advanced instruments and field tools, Dr. Zhao’s laboratory supports:

  • Sediment coring and borehole sampling

  • Chemical characterization of soils and surface sediments

  • Pollutant analysis using ICP-MS, GC-MS, LC-MS/MS
    These resources, combined with strong logistical coordination, enable comprehensive field-to-lab research pipelines.

🔮 Legacy and Future Contributions

Dr. Shizhen Zhao is a rising leader in the fields of environmental geochemistry, sedimentology, and transboundary water health research. Through cutting-edge science and sustained international cooperation, he is paving the way for new understandings of how environmental degradation intersects with human disease. His work not only deepens the knowledge of CKDu but also lays a robust scientific foundation for future environmental health policies and remediation strategies in affected regions.

📖Notable Publications

Aqueous secondary formation substantially contributes to hydrophilic organophosphate esters in aerosols
Journal: Nature Communications
Year: 2025
Citations: 1

Polycyclic aromatics in the Chang’E 5 lunar soils
Journal: Nature Communications
Year: 2025
Citations: 0

Legacy and currently-used pesticides in sedimentary archives: Anthropogenic footprint in the Pearl River Estuary
Journal: Science of the Total Environment
Year: 2025
Citations: 0

Quantification of micro- and nano-plastics in atmospheric fine particles by pyrolysis-gas chromatography-mass spectrometry with chromatographic peak reconstruction
Journal: Journal of Hazardous Materials
Year: 2025
Citations: 0

Heavy metals in atmospheric fine particulate matter (PM2.5) in Dhaka, Bangladesh: Source apportionment and associated health risks
Journal: Environmental Research
Year: 2025
Citations: 0

The Intrinsic Link between Optical Properties and Toxicity of Extractable Organic Matter in Combustion Particles: Mediated by Polycyclic Aromatic Compounds
Journal: Environment and Health
Year: 2025
Citations: 0